Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease
Cristina Bezzio, Lucienne Pellegrini, Gianpiero Manes, Ilaria Arena, Desirée Picascia, C. Della Corte, Massimo Devani, M. Schettino, Simone Saibeni
Abstract
the COVID-19 pandemic.
Topics & Concepts
Inflammatory bowel diseaseMedicineCoronavirus disease 2019 (COVID-19)Inflammatory Bowel Diseases2019-20 coronavirus outbreakDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineMEDLINEGastroenterologyIntensive care medicineVirologyInfectious disease (medical specialty)OutbreakPolitical scienceLawInflammatory Bowel DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies